Evidence map›Paper›PMID 24967703›Full record

ArticlePLoS pathogens2014

MicroRNA-146a provides feedback regulation of lyme arthritis but not carditis during infection with Borrelia burgdorferi.

Robert B Lochhead, Ying Ma, James F Zachary, David Baltimore, Jimmy L Zhao, John H Weis, Ryan M O'Connell, Janis J Weis

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Effect ofMicroorganisms · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Delivery of miR-146a to Ly6CTheranostics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Robert B LochheadDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Ying MaDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
James F ZacharyDepartment of Veterinary Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
David BaltimoreDepartment of Biology, California Institute of Technology, Pasadena, California, United States of America.
Jimmy L ZhaoDepartment of Biology, California Institute of Technology, Pasadena, California, United States of America.
John H WeisDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Ryan M O'ConnellDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Janis J WeisDivision of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
University of Utah · USCalifornia Institute of Technology · USUniversity of Illinois Urbana-Champaign · US

Funding

MOLECULAR GENETICS OF LYME ARTHRITIS SUSCEPTIBILITYR01AR043521 · NIAMS · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 1994 to 2024
$9.4M
BORRELIA BURGDORFERI MITOGEN IN DEVELOPMENT OF ARTHRITISR01AI032223 · NIAID · UNIVERSITY OF UTAH · PI WEIS, JANIS J. · 1993 to 2023
$7.8M
Training Program in Microbial PathogenesisT32AI055434 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MULVEY, MATTHEW A, PLANELLES, VICENTE · 2004 to 2025
$6.0M
MicroRNA Function in the Immune SystemR01AI079243 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BALTIMORE, DAVID · 2008 to 2018
$4.1M
Utilizing TALEN technology to regulate human microRNA'sDP2GM111099 · NIGMS · UNIVERSITY OF UTAH · PI O'CONNELL, RYAN M · 2013 to 2013
$2.2M
Investigate the Role of Micro-RNA 155 in Myeloid Development during InflammationR00HL102228 · NHLBI · UNIVERSITY OF UTAH · PI O'CONNELL, RYAN M · 2011 to 2013
$654k
NHLBI NIH HHS R00 HL102228NHLBI NIH HHS R00HL102228-05NIAID NIH HHS R01 AI032223NIAID NIH HHS R01 AI079243NIAID NIH HHS R01 AI079243ANIAID NIH HHS R01 AI32223NIAID NIH HHS T32 AI055434NIAMS NIH HHS R01 AR043521NIAMS NIH HHS R01 AR43521NIGMS NIH HHS DP2 GM111099
6 · The paper itself

Abstract

MicroRNAs have been shown to be important regulators of inflammatory and immune responses and are implicated in several immune disorders including systemic lupus erythematosus and rheumatoid arthritis, but their role in Lyme borreliosis remains unknown. We performed a microarray screen for expression of miRNAs in joint tissue from three mouse strains infected with Borrelia burgdorferi. This screen identified upregulation of miR-146a, a key negative regulator of NF-κB signaling, in all three strains, suggesting it plays an important role in the in vivo response to B. burgdorferi. Infection of B6 miR-146a-/- mice with B. burgdorferi revealed a critical nonredundant role of miR-146a in modulating Lyme arthritis without compromising host immune response or heart inflammation. The impact of miR-146a was specifically localized to the joint, and did not impact lesion development or inflammation in the heart. Furthermore, B6 miR-146a-/- mice had elevated levels of NF-κB-regulated products in joint tissue and serum late in infection. Flow cytometry analysis of various lineages isolated from infected joint tissue of mice showed that myeloid cell infiltration was significantly greater in B6 miR-146a-/- mice, compared to B6, during B. burgdorferi infection. Using bone marrow-derived macrophages, we found that TRAF6, a known target of miR-146a involved in NF-κB activation, was dysregulated in resting and B. burgdorferi-stimulated B6 miR-146a-/- macrophages, and corresponded to elevated IL-1β, IL-6 and CXCL1 production. This dysregulated protein production was also observed in macrophages treated with IL-10 prior to B. burgdorferi stimulation. Peritoneal macrophages from B6 miR-146a-/- mice also showed enhanced phagocytosis of B. burgdorferi. Together, these data show that miR-146a-mediated regulation of TRAF6 and NF-κB, and downstream targets such as IL-1β, IL-6 and CXCL1, are critical for modulation of Lyme arthritis during chronic infection with B. burgdorferi.

Indexed as

AnimalsArthritis, InfectiousBorrelia burgdorferiChemokine CXCL1Gene Expression RegulationInflammationInflammation MediatorsInterleukin-10Interleukin-1betaInterleukin-6Lyme DiseaseMacrophagesMiceMice, Inbred C3HMice, Inbred C57BLMice, KnockoutChemokine CXCL1Cxcl1 protein, mouseIL10 protein, mouseIL1B protein, mouseInflammation MediatorsInterleukin-10Interleukin-1betaInterleukin-6MicroRNAsMirn146 microRNA, mouseNF-kappa BTNF Receptor-Associated Factor 6

Identifiers

PMID24967703
PMCPMC4072785
OpenAlexW2000931416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.